B21ADDA2-CDB5-4D7B-939A-9020B3018DB0
Position
CEO
Company
LimmaTech Biologics
Location
Schlieren SWITZERLAND
Bio
Veronica is CEO, co-owner and member of the Board of Directors of LimmaTech. Before LImmaTech, she joined GlycoVaxyn AG in 2009 as head of the clinical and regulatory affairs department and was Executive Director at the time of the company’s acquisition by GlaxoSmithKline plc in February 2015. During her 6 years at the firm, Veronica held different positions, from leading the clinical and regulatory department to taking care of business development of the company. Before joining GlycoVaxyn, she held leading roles focused on clinical R&D and international regulatory affairs in medical technology and biotechnology companies, including EndoArt SA and Allergan Inc. Veronica holds an engineering degree from the Swiss Federal Institute of Technology, Zurich (ETH Zurich) and a PhD in life sciences in the field of cardiovascular biomedical engineering from the Swiss Federal Institute of Technology, Lausanne (EPFL).